TENAX THERAPEUTICS, INC. — Director's Dealing 2018

Apr 6, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TENAX THERAPEUTICS, INC. (tenx)
CIK: 0000034956
Period of Report: 2018-04-05

Reporting Person: Jebsen Michael B (CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-03-30	common stock	D	6425	$5.42	Acquired	12310	Direct